Applied Therapeutics, Inc.
APLT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -95.4% | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | $0 |
| % Margin | -10,613% | -439.4% | – | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -22,922.6% | -645.8% | – | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -23,214.1% | -1,198.5% | – | – |
| EPS Diluted | -0.76 | -1.42 | -2.18 | -4.12 |
| % Growth | 46.5% | 34.9% | 47.1% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |